Established in 1958, Liaoyuan City Baikang Pharmaceutical Co., Ltd. is the key manufacturer of APIs and preparations in northeast of China. Originally, it is named as Liaoyuan City First Pharmaceutical Factory and is transformed in to a private enterprise in November, 2003. Nowadays, with the registered capital of 50 million yuan, Liaoyuan City Baikang Pharmaceutical is the wholly owned subsidiary of Chongqing Sansheng Industrial Co., Ltd.
The company is entitled as Provincial Innovative Technology Enterprise, Grade A Taxpayer, Grade AA Bank Credit Unit and Advanced Unit of “Double Love and Double Assessment” many years in succession.
With the experiences of more than 50 years, Liaoyuan City Baikang Pharmaceutical Co., Ltd. is licensed to manufacture 104 kinds of products, including 20 APIs and 84 preparations. The key products of APIs are Paracetamol, Procaine Hydrochloride, Diphenhydramine Hydrochloride, Furazolidone, Piroxicam, Famotidine, Dioxopromethazine Hydrochloride, Nefopam Hydrochlolride, Cloperastine Hydrochloride, Levofloxacin Mesylate, etc. Preparations include Cloperastine Hydrochloride Tablets, Compound Paracetamol and Diphenhydramine Hydrochloride Tablets, etc, with the annual manufacturing capacity of above 2 billion tablets.
Most of the above products are exported to the worldwide markets, such as India, Africa and Taiwan. The company implements our procedures enabling our staffs and system to comply with c GMP practice. And Paracetamol is covered by Certificate of Suitability and is applying for the FDA certificate to develop the US market.
Taking “Honesty, Responsibility, Pragmatism and Efficiency” as the core value, aiming at “Producing the high-quality medicines and caring for the human health”, focusing on the health of people, Liaoyuan City Baikang Pharmaceutical Co., Ltd. assures to control strictly product quality and improve the service continuously to meet the test of the markets. Under the care of the head office, Baikang Pharmaceutical will be better tomorrow!